论文部分内容阅读
本刊讯2014年12月1日,国家食品药品监督管理总局向部分药品生产企业发出警示函,要求对国家药品抽验探索性研究中提示的相关风险信息进行认真排查,及时改进,持续提高药品质量。总局要求各省(区、市)食品药品监督管理部门有针对性地加强对企业的监督管理,督促指导企业排查整改。总局组建以来,坚持以问题为导向开展药品质量抽查检验,强化对药品质量影响因素的探索性研究,以不断提高药品质量保障水平。此次所警示内容是基于药品抽验的探索性研
On December 1, 2014, the State Food and Drug Administration issued warning letters to some drug manufacturers, requiring careful investigation of the relevant risk information prompted by the exploratory research on national drug samples in a timely manner to improve and continuously improve the quality of medicines . The SAIC requires the food and drug supervision and administration departments of all provinces (autonomous regions and municipalities) to strengthen the supervision and management of the enterprises in a targeted manner and supervise and urge enterprises to investigate and rectify the problems. Since the establishment of the General Administration of CPC, we have persisted in taking the problem-oriented test to conduct random inspection of drug quality and strengthened the exploratory research on the factors that affect the quality of pharmaceutical products so as to continuously improve the quality assurance of pharmaceutical products. The warning content is based on the exploratory research of drug testing